DIDO-2 (COSPAR 2017-008BE) is a nano-satellite of the Israeli/Swiss company
SpacePharma.[1] The nano-satellite is part of a research project whose goal is to test a miniaturized end-to-end pharmaceutical laboratory (called mGnify lab) in space under microgravity conditions. The project includes two satellites called DIDO-1 and DIDO-2. The platforms of the 3U CubeSats are developed and built by the Dutch company ISIS.[2]
The first satellite DIDO-1 was originally to fly on a
Falcon 9 in 2016. The current (as of 2019) status and plans for this satellite are unknown.[3]
Launches are separated by dots ( • ), payloads by commas ( , ), multiple names for the same satellite by slashes ( / ).
CubeSats are smaller. Crewed flights are underlined. Launch failures are marked with the † sign. Payloads deployed from other spacecraft are (enclosed in parentheses).